News Today - FDA approves new orphan drug Kynamro to treat inherited cholesterol disorder

[MikeLigalig.com]

FDA approves new orphan drug Kynamro to treat inherited cholesterol disorder

The U.S. Food and Drug Administration today approved Kynamro (mipomersen sodium) injection as an addition to lipid-lowering medications and diet to treat patients with a rare type of high cholesterol called homozygous familial hypercholesterolemia (HoFH). The addition of Kynamro helps to reduce low-density lipoprotein-cholesterol (LDL-C), apolipoprotein B, total cholesterol, and non-high density lipoprotein-cholesterol (non HDL-C).

Source: FDA approves new orphan drug Kynamro to treat inherited cholesterol disorder